Author:
Chow Bing Jie,Lee Isabelle Xin Yu,Liu Chang,Liu Yu-Chi
Abstract
The cornea is an avascular tissue in the eye that has multiple functions in the eye to maintain clear vision which can significantly impair one’s vision when subjected to damage. Peroxisome proliferator-activated receptors (PPARs), a family of nuclear receptor proteins comprising three different peroxisome proliferator-activated receptor (PPAR) isoforms, namely, PPAR alpha (α), PPAR gamma (γ), and PPAR delta (δ), have emerged as potential therapeutic targets for treating corneal diseases. In this review, we summarised the current literature on the therapeutic effects of PPAR agents on corneal diseases. We discussed the role of PPARs in the modulation of corneal wound healing, suppression of corneal inflammation, neovascularisation, fibrosis, stimulation of corneal nerve regeneration, and amelioration of dry eye by inhibiting oxidative stress within the cornea. We also discussed the underlying mechanisms of these therapeutic effects. Future clinical trials are warranted to further attest to the clinical therapeutic efficacy.
Reference102 articles.
1. Maintaining corneal integrity how the “window” stays clear;Kurpakus-Wheater;Prog Histochem Cytochem,2001
2. Molecular nature of ocular surface barrier function, diseases that affect it, and its relevance for ocular drug delivery;Kaur;Ocul Surf,2023
3. Corneal blindness: a global perspective;Whitcher;Bull World Health Organ,2001
4. World report on vision –Executive summary2024
5. Corneal nerves: structure, contents and function;Müller;Exp Eye Res,2003
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献